Romulus Venture Partners

What Romulus Venture Partners does

Romulus Venture Partners LLC is a U.S.-based venture capital and operational consulting firm founded in 2021 that targets early-to-growth stage companies positioned to disrupt industries in Artificial Intelligence, Biotechnology, and Advanced Consumer Products. The firm operates three distinct investment strategies: Venture Building (active partnership with early-stage companies including board involvement, operational support, go-to-market refinement, and capital markets navigation toward IPO or acquisition exits), Activism Strategy (governance-focused investment in undervalued mature companies to optimize cost structures and unlock growth), and Liquidity Strategy (diversification into liquid asset classes to improve DPI and maintain financial flexibility). Investment verticals cover AI (knowledge worker productivity, compute cost declines, open-source model proliferation), Biotechnology (AI/CRISPR-enabled drug discovery, gene therapy, AAV vector engineering, longevity therapeutics), and Advanced Consumer Products (convergence of AI and biotech in longevity, space, robotics, and novel consumer goods).

The firm claims a track record of 800+ investment, advisory, and turnaround projects with $20Bn aggregate transaction value, 30%+ average operational efficiency improvement, and 2-3x revenue growth acceleration for portfolio companies. These figures are self-reported and not independently audited. The business model follows standard VC economics — management fees on assets under management and carried interest on fund returns — augmented by operational consulting services for portfolio companies. Geographic coverage spans the U.S. and China with claimed global market reach.

Go-to-market is direct engagement with prospective portfolio companies through proprietary networks and active board involvement post-investment. Distribution is limited to direct relationships and a website contact form; the firm relies on a Wix-hosted website with an Insights content marketing program publishing long-form sector analyses. No social media presence, paid marketing, or intermediary distribution is disclosed. The firm has 11-50 employees and operates without disclosed fund sizes, AUM, LP commitments, named portfolio companies, or financial performance metrics, leaving material gaps in due diligence visibility.

Name

Romulus Venture Partners

Legal name

Romulus Venture Partners LLC

Website

https://romulusventure.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Romulus Venture Partners is a US-based venture capital and operational consulting firm founded in 2021 that invests in early-to-growth stage companies across AI, Biotechnology, and Advanced Consumer Products via venture building, activism, and liquidity strategies.

Ownership category

akta.pro rank

Product category

Venture Capital and Private Equity

NAICS

Portfolio Management and Investment Advice (523940), Other Financial Investment Activities (5239)

SIC

Investment Advice (6282), Services-Management Consulting Services (8742)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Venture capital investing
• Early stage growth equity
• Operational consulting advisory
• Portfolio company management
• Activist investment strategy

Headquarters

HQ city

Not specified

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Venture Capital Returns (Carried Interest): Generates returns through equity investments in early and growth-stage companies, with carried interest (typically 20% of profits) as the primary value capture mechanism. Exit strategies include IPOs and acquisitions.
2. Management Fees: Collects management fees from funds under management as a standard VC practice to cover operational costs and provide a baseline return to LPs.
3. Operational Consulting Services: Provides operational consulting and advisory services to portfolio companies, including supply chain optimization, production scaling, and execution support. Has executed 800+ investment, advisory and turnaround projects with $20Bn aggregate transaction value.

Distribution channels2 records

Marketing channels1 record

Core offering

Romulus Venture Partners is a venture capital firm that invests in high-potential early-to-growth stage companies in AI, Biotechnology, and Advanced Consumer Products. It offers three strategies — Venture Building, Activism Strategy, and Liquidity Strategy — combining equity capital with active board involvement, operational consulting, go-to-market refinement, and capital markets navigation to position portfolio companies for timely and high-value exits.

Product overview

Romulus Venture Partners is a venture capital firm offering three distinct investment strategies: Venture Building (active partnership with early-stage companies through board involvement, operational support, and exit positioning), Activism Strategy (governance-focused investment in undervalued mature companies for operational improvements), and Liquidity Strategy (liquid asset diversification for fund financial flexibility). The firm operates across three investment verticals: Artificial Intelligence (focusing on advancing AI capabilities and productivity tools), Biotechnology (targeting AI/CRISPR-enabled drug discovery and gene therapy), and Advanced Consumer Products (investing in transformative consumer goods and services). The firm provides operational expertise in supply chain optimization, production scaling, and execution support to portfolio companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Venture Building
• Activism Strategy
• Liquidity Strategy
• AI Investment Focus
• Biotech Investment Focus
• Advanced Consumer Products Investment Focus

Quantifiable outcome

• 800+ investment, advisory and turnaround projects executed
• +3 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Andreessen Horowitz (a16z): One of the largest sector-focused venture firms with dedicated AI, bio/health, and consumer funds plus an explicit operational-support model (a16z operating partners). Highly comparable in thesis and structure, but vastly larger in AUM and team.
• General Catalyst: Large multi-stage venture firm with active operational support (GC 'hatch' platform), investing across AI, healthcare/biotech, and consumer. Comparable in operational value-add philosophy, though broader and better capitalized than Romulus.
• Lightspeed Venture Partners: Multi-stage venture firm with dedicated consumer, enterprise/AI, and health/biotech franchises and active board involvement. Comparable multi-vertical, operationally engaged VC at much greater scale.
• Insight Partners: Large growth-stage venture firm known for hands-on operational support via its Insight Onsite team. Comparable operational-value-add model targeting high-growth software and technology-enabled businesses.
• New Enterprise Associates (NEA): Long-standing multi-stage venture firm with broad sector coverage including healthcare/biotech and consumer/tech. Comparable multi-strategy and multi-vertical approach, though NEA is a much larger and more established institution.

Direct peers

• Khosla Ventures: Sector-focused VC with deep AI and biotech theses and a willingness to take operational involvement in portfolio companies. Closely mirrors Romulus's venture building + vertical specialization model, though at materially greater scale.
• Founders Fund: Early-to-growth stage technology venture firm investing in frontier tech with an active, opinionated operating style. Comparable to Romulus's venture building approach and frontier-tech orientation.
• Lux Capital: Sector-focused venture firm investing at the intersection of science, technology, and frontier categories including AI, biotech, and advanced consumer/space. Closely mirrors Romulus's vertical specialization.

Emerging players

• 8VC: Operationally driven venture builder investing in AI, biotech, and frontier-tech with a build-to-buy orientation. Comparable venture-building style and vertical overlap, at a smaller and more emerging scale than Romulus targets.
• Section 32: Venture fund founded by a former GV partner focused on frontier categories including AI, biotech, and health tech. Comparable sector-focused thesis and emerging scale, with a similar operational orientation.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments13 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Romulus Venture Partners